Long’n Lean ® is a training technique designed to enrich your life with the benefits derived from muscle flexibility and good body posture. The exercises combine structure from yoga and graceful dance stretches in a setting that enhances relaxation. Flexibility training provides many important benefits that cannot beachieved by any other exercise or activity. Try also the fun, advanced Pop Yoga-class with kicks, splits and twists! This is a flow class – a real energizer and work out!

Get your products from the manufacturer to the end customer in the fastest and easiest way possible. Regardless of existing volume or size - NBS provides you with the sales channels, systems, and logistics to reach the whole of Norway. IT-system One system for product registration, sales, statistics, and inventory for your products. Fully integrated with all the services you need. Logistics Efficient logistics from a central warehouse in Vestby of 5,500 m2 specially built for handling beverages. Sales to all channels Sell ​​your products under 4.7% alcohol to private customers through Lokalbrygg.no, over 4.7% alcohol to Vinmonopolet, and everything to HoReCa through horecalevering.no. Marketing and Fairs Increase your visibility through our own fairs for HoReCa, private customers, and Vinmonopolet.

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

MER er et norsk musikkselskap og artistrepresentant. Vår visjon er å bli bransjens beste på å kvalitetssikre, utvikle, fasiliteter og forvalte alle aspekter ved våre klienters karriere og virke. Selskapet har kompetanse og relevant erfaring i å tilby tjenester som management, promo, merkevarebygging og labefunksjoner. MER har de siste årene blitt et internasjonalt selskap med aktivitet over hele verden. Vår største klient, Alan Walker er i dag en av verdens største EDM-artister hvilket gir store muligheter for å bli kjent med en digital musikkverden.

Bad Forecasts Kill Businesses: Working capital cost, natural resource waste, overproduction, lost sales... MIR is the Sherlock Holmes for your business. We identify the most important influence factors out of billions of market data for maximum profit, minimum waste, thanks to the best forecasting accuracy.

A SaaS solution for collecting employee and customer feedback, analysing the data and making informed decisions. We are a growing organisation with offices all over northern europe and with an agenda to change the premises of smart decision making by making feedback an essential part of it. Experience Management for SMEs.

At Relynk, we believe that having insights into a property's real-time data from sensors is the key to unlocking additional value and reducing its environmental impact. That's why we're developing the One API, designed to provide PropTech companies with seamless access to commercial buildings' real-time data.

Pretty miserable out there, isn’t it? We’re in the business of spreading smiles. Glede is a micro gifting platform that enables users to send gifts to friends, family, and co-workers. Through Glede you can send everything from a cup of coffee to a bouquet of flowers, or an experience. Glede makes the sending and receiving of gifts spontaneous, fun, and easy!

Startup Migrants is a company based in Berlin and Oslo. We help cities to boost job creation. We are passionate about collecting and analyzing data that can help cities to solve their challenges. Our data is collected from 15 countries, 45 cities and over 200 in depth interviews with policy makers, entrepreneurs, NGOs and migrant founders. We also have created Startup Preschool, a 3-day crash course in entrepreneurship with and for young multicultural talents. We have so far done 84 Preschools and planning to many more in Norway, Germany, Austria and the UK and other countries. Our more than 1000 participants are now part of an acive alumni group and go on applying to accelerators and starting companies.

We want to revolutionize consumer marketing by helping ambassadors find and promote trustworthy deals. With our technology platform Selectdeal.com, we empower ambassadors to freely choose who and what to recommend, and put our ambassadors in a strong position of influence over both consumer selection of services and service provider innovation going forward. With this we hope to create ethical and sustainable business models that benefit everyone and push everyone in a positive direction.

The Core Service group is more commonly known by its brand name, mcare, and it has been servicing the Nordic market with aftersales processes and authorized Apple repairs since 2010. The company employs over 60 certified Apple experts and has a capacity exceeding a quarter of a million repairs on a yearly basis for the 19 locations spread throughout the Nordics. The revenue for 2019 landed at €22,4M, showing a 20% annual growth. We primarily drive a B2B set-up, having customers within the insurance industry, carriers, and larger well-known enterprises, as well as municipalities and SMEs. Now, we also aim to gain broader recognition amongst consumers.

Our product is very simple: If you sign up, we’ll make sure you get money back if the price drops after your purchase. Through this, we’re aiming to create the shopping companion you never knew you needed. Our vision is to create shopping with peace of mind - imagine a purchase where you never have to worry about overpaying, missing a sale, or getting caught out by the fine print. That’s the future we’re creating. Our office is located in Copenhagen FinTech Lab, one of Europe's leading FinTech Hubs, and we have secured over 1M Euro in funding from Vækstfonden venture, Spring capital, Strawberry capital, and Tinius Trust.

Hayon is a data-driven Fintech company bringing transparency to the mortgage market both for customers and banks. Since the launch in 2020 over 170 000 mortgage customers in Norway have registered on our rapidly growing marketplace Renteradar. Mortgage customers can use Renteradar to get an overview over the mortgage market and how much they can potentially save. In addition Renteradar provides the user with the tools to lower their interest rate by negotiating with their bank or apply for a cheaper loan elsewhere. In addition to Renteradar, Hayon provides analysis about the banking market with Hayon Analytics being the backbone of our offering. Hayon Analytics is an analytical tool built in Power BI providing unique insights to our partners. We are currently eight emplyees but looking to expand our team going forward. Hayon raised capital in beginning of 2023 and the media company Amedia became an investor.